サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：体脂肪減少の世界市場：市場規模 - 施術別、サービスプロバイダー別、ジェンダー別、地域別展望、競合戦略、セグメント別予測（～2030年）
市場調査レポート
商品コード
1159595

体脂肪減少の世界市場：市場規模 - 施術別、サービスプロバイダー別、ジェンダー別、地域別展望、競合戦略、セグメント別予測（～2030年）

Body Fat Reduction Market Size - By Procedure, By Service Provider, By Gender- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 256 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
体脂肪減少の世界市場：市場規模 - 施術別、サービスプロバイダー別、ジェンダー別、地域別展望、競合戦略、セグメント別予測（～2030年）
出版日: 2022年11月02日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 256 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の体脂肪減少の市場規模は、2030年までに161億2,000万米ドルに達し、CAGRで8.2%の成長が予測されています。

体脂肪減少市場は、悪い食習慣、ライフスタイルの変化、運動不足、座りがちなライフスタイルによってもたらされる肥満事例の増加、および肥満に対する政府の政策やプログラムにより、施術の採用が促進されています。より低価格で、侵襲性、不快感が少なく、結果のリスクも低いことから、低侵襲性治療法は、市場を独占すると予測されます。

当レポートでは、世界の体脂肪減少市場について調査し、市場力学、市場変数と見通し、施術・サービスプロバイダー・ジェンダー・地域別の市場分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • 市場セグメント分析

第2章 調査手法

  • 調査データソース
  • 市場規模の推定
  • データの三角測量

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因、抑制要因、機会、課題の分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 世界の体脂肪減少市場におけるCOVID-19の影響

第5章 市場変数と見通し

  • SWOT分析
    • 強み
    • 弱み
    • 機会
    • 脅威
  • PESTEL分析
    • 政治情勢
    • 経済情勢
    • 社会情勢
    • 技術情勢
    • 環境情勢
    • 法的情勢
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入者の脅威
    • 競合企業間の敵対関係
  • ヒートマップ分析

第6章 世界の体脂肪減少市場：施術別、2019年～2030年（100万米ドル）

  • 外科的
    • 腹部形成術
    • 脂肪吸引
  • 非外科的
    • 超音波
    • 凍結脂肪分解法
    • その他

第7章 世界の体脂肪減少市場：サービスプロバイダー別、2019年～2030年（100万米ドル）

  • 病院
  • クリニック
  • 医療スパ
  • その他

第8章 世界の体脂肪減少市場：ジェンダー別、2019年～2030年（100万米ドル）

  • 女性
  • 男性

第9章 世界の体脂肪減少市場：地域別、2019年～2030年（100万米ドル）

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • 中東・アフリカ
    • サウジアラビア王国
    • アラブ首長国連邦
    • その他の中東・アフリカ

第10章 企業プロファイル

  • AbbVie Inc. (Allergan Inc.)
    • 企業概要
    • 財務見通し
    • 製品概要
    • 最近の開発
  • Apollo Hospitals Enterprise Limited
  • Bausch Health Companies Inc.
  • Cutera, Inc.
  • Candela Medical
  • Cynosure, Llc
  • Lumenis Ltd
  • Sciton Inc.
  • Sisram Medical Ltd
  • VLCC Health Care Limited
目次
Product Code: HLCA2215

Global Body Fat Reduction Market Overview:

According to SPER Market Research, the Global Body Fat Reduction Market is estimated to reach USD 16.12 billion by 2030 with a CAGR of 8.2%.

Body fat reduction is the term used to describe a reduction in total body weight brought on by the loss of fluid, adipose tissue, or lean mass, including bone mineral deposits, muscle, tendon, and other connective tissue. It is the process of reducing extra body fat with a variety of goals in mind, such as improving the shape and appearance of the body. Adipose tissue, or body fat, has particular roles in the metabolism and endocrine system. The removal of extra adipose tissue or fats from the body via surgical or non-surgical means is a common practice in cosmetic surgery. there are many treatments on the market, including abdominoplasty (tummy tuck), laser lipolysis, cryolipolysis, liposuction, ultrasound, red light therapy, and injectable therapy.

Obesity is a growing public health issue in both industrialised and emerging nations, largely due to the population's unhealthy, stressful lifestyle. In addition to genetic, physiological, and environmental factors, eating habits, exercise preferences, and physical activity levels all contribute to obesity. People use surgical and non-surgical methods to achieve their goal of losing body fat. thus, it is anticipated that the body fat reduction market will grow due to the rise in obesity cases brought on by bad eating habits, lifestyle changes, lack of exercise, and adoption of a sedentary lifestyle, as well as favourable government policies and programmes for obesity that are encouraging the adoption of body fat reduction procedures.

Due to its emphasis on minimum blood loss, shorter patient stays, safety, and convenience of use, minimally invasive therapy approaches for body fat removal are becoming more and more popular. Because they are more affordable, less intrusive, and uncomfortable, and have a lower risk of consequences, minimally invasive procedures are predicted to dominate the market. The procedure of enhancing the appearance of the face and body is known as aesthetic plastic surgery (sometimes referred to as cosmetic surgery). Increased demand for surgical and non-surgical body contouring or body shaping procedures also contributes to the market's expansion.

In addition, surgeries to lose weight or alter the body after childbirth are becoming more popular. Young people and women are becoming more conscious of their physical appearance and fitness levels in order to achieve body slimming. Therefore, it is anticipated that these factors will significantly drive the expansion of the body fat reduction market over the forecast period.

The global fat reduction market is segmented n the basis of procedure, service provider and gender. On the basis of procedure, the surgical segment dominated the market is expected to dominate the market during forecast period due to rising demand for weight loss and obesity treatments and aesthetic improvement operations. On the basis of service provider, hospitals and clinics subsegment is expected to dominate during the forecast period. On the basis of gender, the female subsegment will dominate the market due to elf-conscious about having attractive and artistic appearances. However, the high cost of these procedures and some side effects following therapy are anticipated to hinder market expansion.

Impact of COVID-19 on the Global Body Fat Reduction Market

The COVID-19 pandemic has had a significant negative influence on the expansion of the body fat reduction sector since it has temporarily halted some medical treatments and suspended some aesthetic treatment procedures. However, a rise in weight gain difficulties was caused by the temporary closure of fitness centres and the adoption of the work from home (WFH) culture, which is predicted to spur market expansion over the course of the projection period.

Scope of the report

Report Metric Details

Market size available for years 2019-2030

Base year considered 2021

Forecast period 2022-2030

Segments covered By Procedure, By Service Provider, By Gender

Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Covered AbbVie Inc. (Allergan Inc.), Apollo Hospitals Enterprise Limited, Bausch Health Companies Inc., Cutera, Inc., Candela Medical, Cynosure, Llc, Lumenis Ltd, Sciton Inc., Sisram Medical Ltd, Vlcc Health Care Limited.

Global Body Fat Reduction Market Segmentation:

By Procedure: Based on the Procedure, Global Body Fat Reduction Market is segmented as; Surgical (Abdominoplasty, Liposuction), Non-Surgical (Ultrasound, Cryolipolysis, Others).

By Service Provider: Based on the Service Provider, Global Body Fat Reduction Market is segmented as; Hospitals, Clinics, Medical Spas, Others.

By Gender: Based on the Gender, Global Body Fat Reduction Market is segmented as; Females and Males.

By Region: North America is expected to maintain its leadership position during the projection period. Due to the rising frequency of obesity cases, the existence of important players, an increase in healthcare spending, technological improvements, and an increase in regional government efforts.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Body Fat Reduction Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Body Fat Reduction Market, By Procedure, 2019-2030 (USD Million)

  • 6.1 Surgical
    • 6.1.1 Abdominoplasty
    • 6.1.2 Liposuction
  • 6.2 Non-Surgical
    • 6.2.1 Ultrasound
    • 6.2.2 Cryolipolysis
    • 6.2.3 Others

7. Global Body Fat Reduction Market, By Service Provider, 2019-2030 (USD Million)

  • 7.1 Hospitals
  • 7.2 Clinics
  • 7.3 Medical Spas
  • 7.4 Others

8. Global Body Fat Reduction Market, By Gender, 2019-2030 (USD Million)

  • 8.1 Females
  • 8.2 Males

9 Global Body Fat Reduction Market, By Region, 2019-2030 (USD Million)

  • 9.1 North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2 Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4 South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5 Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10 Company Profiles

  • 10.1 AbbVie Inc. (Allergan Inc.)
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2 Apollo Hospitals Enterprise Limited
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3 Bausch Health Companies Inc.
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4 Cutera, Inc.
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5 Candela Medical
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6 Cynosure, Llc
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7 Lumenis Ltd
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8 Sciton Inc.
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9 Sisram Medical Ltd
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. VLCC Health Care Limited
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments